[1] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2016[J].CA J Clin,2016,66(1):7-30.
[2] GRONBERG H.Prostate cancer epidemiology[J].Lancet,2003,361(9360):859-864.
[3] HUNTER D J,KRAFT P.Drinking from the fire hose——statistical issues in genomewide association studies[J].N Engl J Med,2007,357(5):436-439.
[4] ISHAK M B,GIRI V N.A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genomewide association studies[J].CA Epid Bio Prev,2011,20(8):1599-1610.
[5] GUDMUNDSSON J,SULEM P,STEINTHORSDOTTIR V,et al.Two variants on chromosome 17confer prostate cancer risk,and the one in TCF2 protects against type 2 diabetes[J].Nat Genet,2007,39(8):977-983.
[6] ZHENG S L,SUN J,WIKLUND F,et al.Cumulative association of five genetic variants with prostate cancer[J].N Engl J Med,2008,358(9):910-919.
[7] 李星慧,张政,张毓洪,等.EEFSEC基因、染色体17q24和染色体11q13.2基因变异与前列腺癌的关联研究[J].中国老年保健医学,2015,13(1):5-9.
[8] MAO W G,HE H Q,XU Y,et al.Powerful haplotype-based Hardy-Weinberg equilibrium tests for tightly linked loci[J].PLoS One,2013,8(10):e77399.
[9] LITTLE J,HIGGINS J P,IOANNIDIS J P,et al.STrengthening the REporting of Genetic Association studies (STREGA)-an extension of the STROBE statement[J].Eur J Clin Invest,2009,39(4):247-266.
[10] CHAN J Y,LI H,SINGH O,et al.8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort[J].Urol Oncol,2013,31(8):1553-1560.
[11] LIU M,SUZUKI M,ARAI T,et al.A replication study examining three common single-nucleotide polymorphisms and the risk of prostate cancer in a Japanese population[J].Prostate,2011,71(10):1023-1032.
[12] ROJAS P A,TORRES E V,CERDA I J,et al.Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population[J].J Cancer Res Clin Oncol,2014,140(5):783-788.
[13] ZHANG Y R,XU Y,YANG K,et al.Association of six susceptibility Loci with prostate cancer in northern chinese men[J].Asian Pac J Cancer Prev,2012,13(12):6273-6276.
[14] ZHOU C H,WANG J Y,CAO S Y,et al.Association between single nucleotide polymorphisms on chromosome 17q and the risk of prostate cancer in a Chinese population[J].Chin J Cancer,2011,30(10):721-730.
[15] EGGER M,DAVEY S G,SCHNEIDER M,et al.Bias in meta-analysis detected by a simple,graphical test[J].BMJ,1997,315(7109):629-634.
[16] BETHESDA.Genetics of Prostate Cancer[PDQ(R)]:Health Professional Version[M].PDQ Cancer Information Summaries.USA:National Cancer Institute,2002.
[17] WANG H,LEAV I,IBARAG I S,et al.SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion[J].Cancer Res,2008,68(6):1625-1630.
[18] WANG H,MCKNIGHT N C,ZHANG T,et al.SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells[J].Cancer Res,2007,67(2):528-536.
[19] ZHANG X,COWPER S R,BAILEY S D,et al.Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus[J].Genome Res,2012,22(8):1437-1446. |